Satsuma Pharmaceuticals Inc (STSA) |
|
6.46 0 (0%)
|
03-07 03:55 |
|
Open: |
6.5 |
Pre. Close: |
6.46 |
|
High:
|
6.85 |
Low:
|
6.3001 |
|
Volume:
|
410,031 |
Market Cap:
|
113M |
|
|
|
|
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 16 full-time employees. The firm is focused on developing a therapeutic product for the treatment of migraine. The Company’s product candidate STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate (DHE), which can be self-administered with a proprietary pre-filled, single-use, nasal delivery device. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.856 - 6.89 |
6.89 - 6.918 |
|
Low:
|
6.225 - 6.261 |
6.261 - 6.292 |
|
Close:
|
6.405 - 6.462 |
6.462 - 6.511 |
|
Technical analysis |
as of: 2021-03-05 5:13:37 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 7.89  One year: 8.72 |
| Support: |
Support1: 5.59 Support2: 4.65 |
| Resistance: |
Resistance1: 6.75 Resistance2: 7.47 |
| Pivot: |
6.44  |
| Moving Average: |
MA(5): 6.53 MA(20): 6.55
MA(100): 5.06 MA(250): 14.32 |
| MACD: |
MACD(12,26): 0.13 Signal(9): 0.17 |
| Stochastic oscillator: |
%K(14,3): 56.53 %D(3): 53.25 |
| RSI: |
RSI(14): 52.48 |
| 52-week: |
High: 36.10 Low: 3.50 Change(%): -74.8 |
| Average Vol(K): |
3-Month: 51698 10-Days: 66443 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.STSA has closed below upper band by 48.9%. Bollinger Bands are 43.8% wider than normal. The large width of the bands suggest high volatility as compared to STSA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 04 Mar 2021
Where Will Satsuma Pharmaceuticals Inc (STSA) Stock Go Next After It Is Higher By 14.81% in a Week? - InvestorsObserver
Wed, 03 Mar 2021
InvestorNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report - StreetInsider.com
Wed, 03 Mar 2021
Where Does Wall Street Think Satsuma Pharmaceuticals Inc (STSA) Stock Will Go? - InvestorsObserver
Tue, 02 Mar 2021
Satsuma Pharmaceuticals : Credit Suisse Upgrades Satsuma Pharmaceuticals to Neutral from Underperform After Disclosing Go-Forward Plan STS101 Program - marketscreener.com
Tue, 02 Mar 2021
Leerink Partners Maintains Their Hold Rating on Satsuma Pharmaceuticals (STSA) - Smarter Analyst
Mon, 01 Mar 2021
Satsuma Pharmaceuticals Inc (STSA) Stock Is Up 7.57% This Week: Buy, Hold, or Sell? - InvestorsObserver
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
17 |
| Shares Float (M) |
9 |
|
% Held by Insiders
|
10.84 |
|
% Held by Institutions
|
56.83 |
|
Shares Short (K)
|
476 |
|
Shares Short P. Month (K)
|
816 |
Stock Financials |
|
EPS
|
-11.200 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
7.030 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-26.8 |
|
Return on Equity (ttm)
|
-45.6 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.693 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-41 |
|
Levered Free Cash Flow (M)
|
-26 |
Stock Valuations |
|
PE Ratio
|
-0.58 |
|
PEG Ratio
|
|
|
Price to Book value
|
0.92 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-2.75 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
